Table 3—

Sensitivity analysis for evaluation rates for teleophthalmology and nonteleophthalmology

Nonteleophthalmology
Evaluation ratio of teleophthalmology
Evaluation ratioBaseline C/E0%20%40%60%75%*80%100%
Cost5%$16,929$12,823$13,807$14,791$15,776$16,514$16,760$17,744
QALYs18.51818.50318.56218.62118.68018.72518.73918.798
ICERNEDominatedDominatedDominatedDominatedDominated$2,905
Cost25%*$17,590$12,823$13,807$14,791$15,776$16,514$16,760$17,744
QALYs18.57718.50318.56218.62118.68018.72518.73918.798
ICERNENEDominatedDominatedDominatedDominated$694
Cost45%$18,252$12,823$13,807$14,791$15,776$16,514$16,760$17,744
QALYs18.63618.50318.56218.62118.68018.72518.73918.798
ICERNENENEDominatedDominatedDominatedDominated
Cost65%$18,914$12,823$13,807$14,791$15,776$16,514$16,760$17,744
QALYs18.69518.50318.56218.62118.68018.72518.73918.798
ICERNENENENEDominatedDominatedDominated
  • NE indicates that teleophthalmology has a negative incremental effectiveness to nonteleophthalmology. Dominated denotes that nonteleophthalmology is dominated by teleophthalmology.

  • *

    * Baseline value in reference case. C/E, cost-effectiveness.